HIGHLIGHTS
- who: Elie El Agha and Malgorzata Wygrecka from the (UNIVERSITY) have published the research work: State of the Art in Idiopathic Pulmonary Fibrosis, in the Journal: Cells 2022, 11, 2487. of 11/08/2022
- how: Analysis of the remaining patient data showed that the discontinuation rate was around half within one year of treatment.
- future: Despite immense improvements in understanding the molecular basis of IPF further research is urgently needed to pursue innovative translational studies to learn more about the enormous repertoire of molecular tricks that lung cells use to adapt to stress . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.